Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by eSnowdenon Nov 18, 2016 10:10am

160 Views

Post# 25480285

RE:More colour on this very positive acquisition

I like it, I like it, I like it...with a sales force intact, we our setting ourselves up to be a Teva-competitor. Medicure needed another revenue stream long term with Aggrastat patents expiring & this is more than an investor could ask for. As for Apicore, google Glassdoor Apicore and hear what employees have to say. Dr. Friessen, Thank you!!

Bullboard Posts

B2Gold stock buckles under news of labour strike in Mali